medigraphic.com
ISSN 1817-5996 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cub de Reu 2013; 15 (2)

Sjögren's syndrome and pregnancy

Hernández CIM, Reyes PY, Hernández CMV, López MAM, Gil AR, Prada HD, Molinero RC

Language: Spanish
References: 26
Page:
PDF size: 118.14 Kb.


ABSTRACT

Primary Sjögren's syndrome is an autoimmune exocrinopathy of slow progression and chronic, that causes sicca symptoms due to lymphocytic T infiltration that leads to the destruction of the exocrine glands. Clinically it is characterized by ocular and oral dryness However, more than half of the patients develop extraglandular manifestations that can concern any organ, can be the first manifestation of the syndrome and which are going to determine the prognosis. In de women pregnancy, and primary or secundary Sjögren's síndrome, is necesary the electrocardiographic screening in all infants born to mothers with anti-Ro/La antibodies to identify those with heart conduction abnormalities. Electrocardiographic abnormalities at birth is frecuently asymptomatic infants. There are presented sinus bradycardia, the second abnormalities of ventricular repolarization, both regressed spontaneously, while the third ventricular extrasystoles which continue even now at someone months. A 3rd degree block in the mother, and causing pregnancy termination.


REFERENCES

  1. Fox RI. Sjogren's syndrome. Lancet. 2005;366:321-31.

  2. Martínez Larrarte José Pedro, Reyes Pineda Yusimí. Síndrome de Sjögren. Rev cubana med [revista en la Internet]. 2010 Jun [citado 2013 abril 19]. 49(2): . Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232010000200006&lng=es

  3. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164:1275-84.

  4. Ramos-Casals M, Font J. Primary Sjogren's syndrome: current and emergent a etiopathogenic concepts. Rheumatology. 2005;44:1354-67.

  5. González Céspedes Osvaldo, Santos Fabré Elugerio, Núńez Pupo Noidis. Síndrome de Sjögren. MEDISAN [revista en la Internet]. 2011 Dic [citado 2013 abril 19] ; 15(12): 1784-1809. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S109-30192011001200016&lng=es

  6. Ramos-Casals M, Solans S, Rosas J, Camps MT, Gil A, Del Pino-Montes J, Calvo-Alen J. et al. Primary Sjögren syndrome in Spain: Clinical and immunologic expression in 1010 patients. Medicine;2008;87(4):210-9.

  7. Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, Schiřdt M, et al. American College of rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care and Research. 2012;64(4):475-87.

  8. Mathews SA, Kurien BT, Scofield RH. Oral manifestations of Sjögren's syndrome. Journal of Dental Research. 2008);(4):308-18.

  9. Soy M, Piskin S. Cutaneous findings in patients with primary Sjogren's syndrome. Clinical Rheumatology. 2007;26(8):1350-2.

  10. Parke AL.Pulmonary Manifestations of Primary Sjögren's Syndrome. Rheumatic Disease Clinics of North America. 2008;34(4):907-20.

  11. Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. Journal of Clinical Gastroenterology. 2012;46(1):25-30.

  12. Ramíre M, Ramos-Casals M, Graus F. Central nervous system involvement in primary Sjögren syndrome. Medicina Clinica. 2009;133 (9):349-59.

  13. Rosas Gómez de Salazar J, Senabre Gallego JM, Santos Ramírez C. Management of the extraglandular manifestations of primary Sjögrens syndrome. Reumatologia Clinica. 2010; suple 2(6):6-11.

  14. Nikolov NP, Illei GG.Pathogenesis of Sjögren's syndrome. Current Opinion in Rheumatology. 2009;21(5):465-70.

  15. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-8.

  16. Devauchelle-Pensec V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse-Joulin S. Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum.2007;57:310-7.

  17. Touma Z, Sayad J, Arayssi T. Successful treatment of Sjogren's syndrome with rituximab. Scand J Rheumatol. 2006;35:323-5.

  18. Meijer JM, Meiners PM, Vissink A, Spijkervet FKL, Abdulahad W, Kamminga N, Brouwer E, et al. Effectiveness of rituximab treatment in primary sjögren's syndrome: A randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism. 2010;62(4):960-8.

  19. Pijpe J, Meije JM, Bootsma H, Van Der Wal JE, Spijkervet FKL, Kallenber, C.M, Vissink, et al. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome. Arthritis and Rheumatism. 2009;60(11):3251-6.

  20. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: A systematic review. JAMA. 2010;304(4):452-60.

  21. Fernández Castro M , Silva L, Otón T, Andreu JL. Etiologic treatment of sicca syndrome. What can the rheumatologist offer? Reumatologia Clinica. 2010; Suple.2 (6):1-5.

  22. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, et al. EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): Development of a consensus patient index for primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 2011.70(6):968-72.

  23. Elvira A, Oyarzabal A, Murgiondo A, Paredes J, Juaristi G. Muerte fetal anteparto y síndrome de Sjögren oculto. Clinica e Investigacion en Ginecologia y Obstetricia.2010;37(1):41-4.

  24. Palomba S, Russo T, Sacchinelli A, Oppedisano R, Falbo A, Sena T, Zullo F, Mastrantonio P. Manifestazioni extraghiandolari della sindrome di Sjögren: Implicazioni in ginecologia e ostetricia. Minerva Ginecologica. 2008;60(2): 183-8

  25. Grava C, Ruffatti A, Milanesi O, Favaro M, Tonello M, Calligaro A, Del Ross T, Todesco S. Isolated congenital heart block in undifferentiated connective tissue disease and in primary Sjögren's syndrome: A clinical study of 81 pregnancies in 41 patients. Reumatismo. 2005;57(3):180-6.

  26. Ramos-Casals M, Tzioufas AG, Font J. Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64:347-54.




2020     |     www.medigraphic.com